SHANGHAI, July 29,
2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or
the "Company"), a leading tech-enabled healthcare platform company
committed to reshaping the value chain of healthcare industry by
digitally empowering the upstream and downstream in China, today announced that it will report its
unaudited financial results for the second quarter ended
June 30, 2024, before the U.S. market
opens on Thursday, August 29,
2024.
111's management team will host an earnings conference call at
7:30 AM U.S. Eastern Time on
Thursday, August 29, 2024
(7:30 PM Beijing Time on the same
day).
Details for the conference call are as follows:
Conference Topic: 111, Inc. Second Quarter 2024 Earnings
Conference Call
Registration Link:
https://s1.c-conf.com/diamondpass/10040837-g09iyj.html
All participants must use the link provided above to complete
the online registration process in advance of the conference call.
Upon registering, each participant will then be provided with the
dial in number, the Passcode, and your unique access PIN. This
information will also be emailed to you as a calendar invite.
Please dial in 15 minutes before the call is scheduled to begin.
To join the conference, simply dial the number in the calendar
invite and enter the passcode followed by your PIN, and you will
join the conference instantly.
A live and archived webcast of the conference call will be
available on the website at
https://edge.media-server.com/mmc/p/a2w3gscg.
A telephone replay of the call will be available after the
conclusion of the conference call until September 5, 2024.
China: 4001209216
United States: +1-855-883-1031
International: +61-7-3107-6325
Conference ID: 10040837
About 111, Inc.
111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading
tech-enabled healthcare platform company committed to reshaping the
value chain of healthcare industry by digitally empowering the
upstream and downstream in China.
The Company provides consumers with better access to pharmaceutical
products and healthcare services directly through its online retail
pharmacy, 1 Pharmacy, and indirectly through its offline virtual
pharmacy network. The Company also offers online healthcare
services through its internet hospital, 1 Clinic, which provides
consumers with cost-effective and convenient online consultation,
electronic prescription service, and patient management service. In
addition, the Company's online platform, 1 Medicine, serves as a
one-stop shop for pharmacies to source a vast selection of
pharmaceutical products. With the largest virtual pharmacy network
in China, 111 enables offline
pharmacies to better serve their customers with cloud-based
services. 111 also provides an omni-channel drug commercialization
platform to its strategic partners, which includes services such as
digital marketing, patient education, data analytics, and pricing
monitoring.
For more information on 111, please visit:
http://ir.111.com.cn/.
View original
content:https://www.prnewswire.com/news-releases/111-to-announce-second-quarter-2024-unaudited-financial-results-on-august-29-2024---conference-call-to-follow-302207290.html
SOURCE 111, Inc.